Jagat R. Kanwar
Jagat R. Kanwar is an immunologist and molecular biochemist with an international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. He did his Ph.D. from Post Graduate Institute of Medical Education and Research, Chandigarh, India. Before joining Deakin University in 2006, he was a Senior Scientist/Senior Research Fellow in the University of Auckland, Auckland, New Zealand. During the past decade his research both academic and commercial has centered on understanding the pathophysiological mechanisms and/or finding treatments for a variety of chronic inflammatory diseases and different types of cancer. Kanwar has published 55 research articles, 12 invited reviews and 5 book chapters, in highly ranked, international, peer-reviewed journals. These publications have added to the body of knowledge in the fields of immunology, cancer gene therapy, nanomedicine, cell biology and biotechnology, and have extended these disciplines. He is a key inventor on 9 international patents and has provided consultancy to 5 Biotechnology based companies. He is a member of editorial board for 7 international journals and a nominated member of more than 12 national and international societies including American Society of Nanomedicine. He has extensive and close collaborations with colleagues from New Zealand, Australia, Singapore, India, China and USA.
Nanotechnology based drug delivery of proteins/peptides, siRNA and miRNA to target cancer and chronic inflammation.
Drug discovery for novel anticancer targets for cancer cell survival, death, arrest, and repair.
Development of immunomodulatory and anti-inflammatory bioactives, proteins and peptides for neuroprotection.
Development of complementary alternative medicine from the milk derived proteins including metal binding protein Lactoferrin, and herbal preparation derived active components with a special focus on the treatment of solid tumours colon and breast cancers.